Blauvelt, A., Fowler, Jr., J. F., Schuck, E., Jauch, J., Woehling, H., & Leonardi, C. L. (2017). A Randomized, Double-Blind, Multicenter Study to Compare the Efficacy, Safety, and Immunogenicity of a Proposed Adalimumab Biosimilar (GP2017) with Originator Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 1(3.1), s29.